Gene · 25939
Papers2,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer. | Cell Oncol (Dordr) | 2024 | 37667113 | PubTator, text mining | PubMed |
| Caspase 5 depletion is linked to hyper-inflammatory response and progeroid syndrome. | Geroscience | 2024 | 37603195 | PubTator, text mining | PubMed |
| Metabolic Enzymes in Viral Infection and Host Innate Immunity. | Viruses | 2023 | 38257735 | PubTator, text mining | PubMed |
| The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis. | Viruses | 2023 | 38257728 | PubTator, text mining | PubMed |
| RNASEH2B Pathogenic Mutation Presenting with Pure, Apparently Non-Progressive Hereditary Spastic Paraparesis. | Ann Indian Acad Neurol | 2023 | 38229641 | PubTator, text mining | PubMed |
| Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection. | Int J Mol Sci | 2023 | 38203551 | PubTator, text mining | PubMed |
| Highlights from the Inaugural HIV Reservoirs and Immune Control Conference, October 1st-4th 2023, Malahide Ireland. | Pathog Immun | 2023 | 38155941 | PubTator, text mining | PubMed |
| Comparative Application of Terminal Restriction Fragment Analysis Tools to Large-Scale Genomic Assays. | Int J Mol Sci | 2023 | 38139024 | PubTator, text mining | PubMed |
| Special Issue: Immune-Mediated Neurological Disorders. | Biomedicines | 2023 | 38137435 | PubTator, text mining | PubMed |
| Roles of Human Endogenous Retroviruses and Endogenous Virus-Like Elements in Cancer Development and Innate Immunity. | Biomolecules | 2023 | 38136578 | PubTator, text mining | PubMed |
| Susceptibility Genes Associated with Multiple Primary Cancers. | Cancers (Basel) | 2023 | 38136334 | PubTator, text mining | PubMed |
| A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor. | Cell Death Discov | 2023 | 38135680 | PubTator, text mining | PubMed |
| Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach. | Front Neurol | 2023 | 38125829 | PubTator, text mining | PubMed |
Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma. | Heliyon | 2023 | 38125466 | PubTator, text mining | PubMed |
| Ischemic Stroke Thrombus Perviousness Is Associated with Distinguishable Proteomic Features and Susceptibility to ADAMTS13-Augmented Thrombolysis. | AJNR Am J Neuroradiol | 2023 | 38123915 | PubTator, text mining | PubMed |
| Advances in transposable elements: from mechanisms to applications in mammalian genomics. | Front Genet | 2023 | 38098473 | PubTator, text mining | PubMed |
| LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities. | Genes Dev | 2023 | 38092519 | PubTator, text mining | PubMed |
| Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils. | Front Immunol | 2023 | 38090576 | PubTator, text mining | PubMed |
| A zebrafish model of Ifih1-driven Aicardi-Goutières syndrome reproduces the interferon signature and the exacerbated inflammation of patients. | Front Immunol | 2023 | 38077314 | PubTator, text mining | PubMed |
| Eukaryotic CD-NTase, STING, and viperin proteins evolved via domain shuffling, horizontal transfer, and ancient inheritance from prokaryotes. | PLoS Biol | 2023 | 38064485 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25939/papers?page=11